Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 4 49-4, 2001, Pages

  Beglinger, Christoph ^a   Degen, Lukas ^a   Matzinger, Daniel ^a   D'Amato, Massimo ^b   Drewe, Jürgen ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Rotta Research Laboratorium   (Italy)

Author keywords

Appetite; Cholecystokinin; Eating behavior

Indexed keywords

CHOLECYSTOKININ A RECEPTOR ANTAGONIST; LOXIGLUMIDE;

ADULT; APPETITE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; DRUG EFFECT; ENERGY METABOLISM; FEEDING BEHAVIOR; FOOD INTAKE; GALLBLADDER CONTRACTION; HUMAN; HUNGER; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SATIETY; STIMULUS RESPONSE;

EID: 0035021861     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.4.r1149     Document Type: Article

References (71)

1. Cholecystokinin-A receptor mediation of food intake in cats
2. Dietary fat and the control of energy intake: Evaluating the effects of fat on meal size and postmeal satiety
3. Control of human appetite: Implications for the intake of dietary fat
4. CCK antagonists and CCK-monoamine interactions in the control of satiety
5. CCK-A receptors in gastrointestinal disorders
6. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans
7. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid
8. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans
9. The effects of loxiglumide on food intake in normal weight volunteers
10. Adaptation to high-fat diets: Effects on eating behaviour and plasma cholecystokinin
11. Is cholecystokinin a satiety hormone? Correlations of plasma cholecystokinin with hunger, satiety and gastric emptying in normal volunteers
12. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide
13. Control of food intake. A physiologically complex, motivated behavioral system
14. Satiety: The roles of peptides from the stomach and the intestine
15. Cholecystokinin decreases food intake in rats
16. Cholecystokinin elicits satiety in rats with open gastric fistulas
17. Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat
18. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
19. Effect of intravenous human gastrin-releasing peptide on food intake in humans
20. Glucagon-like peptide-1: A potent regulator of food intake in humans
21. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients
22. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides
23. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man
24. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans
25. Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential
26. C-terminal octapeptide of cholecystokinin decreases food intake in man
27. Physiology of the control of food intake
28. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight
29. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK
30. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction
31. Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhibitor, and alcohol
32. Regulation of gastric emptying in humans by cholecystokinin
33. Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanism
34. Role of cholecystokinin in the regulation of satiation and satiety in humans
35. Satiety effects of a physiological dose of cholecystokinin in humans
36. Effect of a low dose of intraduodenal fat on satiety in humans: Studies using the type A cholecystokinin receptor antagonist loxiglumide
37. Satiety effects of cholecystokinin in humans
38. Cholecystokinin and leptin act synergistically to reduce body weight
39. Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight
40. Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans
41. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys
42. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK
43. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin
44. Disordered food intake and obesity in rats lacking cholecystokinin A receptors
45. Cholecystokinin suppresses food intake by inhibiting gastric emptying
46. Gastric and nongastric mechanisms for satiety action of cholecystokinin
47. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers
48. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue
49. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man
50. Effect of a soup preload on reduction of food intake by cholecystokinin in humans
51. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
52. Role of cholecystokinin in the control of food intake
53. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats
54. The role of the gut in regulating food intake in man
55. Cholecystokinin as satiety signal
56. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats
57. Comparative effects of caerulein on food intake and pancreatic secretion in dogs
58. Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats
59. The direct and indirect controls of meal size
60. The therapeutic potential of cholecystokinin
61. Cholecystokinin: A putative satiety signal
62. Gut peptides and postprandial satiety
63. Cholecystokinin and intestinal satiety in the rat
64. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat
65. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9-to 12-day-old rat pups
66. A role for glucagon-like peptide-1 in the central regulation of feeding
67. Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers
68. Comparisons of the effects on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine
69. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist